Drug therapy of overactive bladder - What is coming next?
After the approval and introduction of mirabegron, tadalafil, and botulinum toxin A for treatment of lower urinary tract symptoms/overactive bladder, focus of interest has been on their place in therapy versus the previous gold standard, antimuscarinics. However, since these agents also have limitat...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
The Korean Urological Association
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610893/ |